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Gastrointestinal microflora has been shown to have a bi-directional relationship with the 
host immune system.  A variety of fermentable carbohydrate polymers largely pass 
through the small intestine, providing fermentable substrates for gut microflora.  Dietary 
fibre supplementation may provide a strategy for manipulating the intestinal bacterial 
profile, changing the interaction with the mucosal immune system, thereby modulating 
the host immune system.  We used a BBc rat animal model to evaluate the effects of oat 
bran and wheat bran dietary fibre on the immune system.  Previous collaborative efforts 
have shown that these dietary fibres can change the intestinal microflora, with wheat bran 
fibre showing a greater ability to influence colonic microbial community diversity.  We 
have shown that dietary wheat bran fibre led to reduced IL-4 levels in the liver and T 
lymphocyte numbers in the Mesenteric Lymph Node and may be involved in reduced 
IgA levels in the cecal contents.  In addition, IgA in the cecal contents was decreased 
while MLN B cell numbers increased in response to dietary wheat bran fibre.    It was 
observed that neither wheat bran or oat bran treatments exerted any pro-inflammatory 
effects, with oat bran actually improving antioxidant status. These results suggest that 
both oat and wheat bran fibre treatments induce changes in the intestinal microflora, and 
that the microflora changes due to wheat fibre are associated with immunomodulatory 
effects on the host.  This type of dietary fibre supplementation could ultimately provide a 
potential strategy for promoting health through microflora-associated effects on the 
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In recent years, there has been an increase in the focus on interactions between 
intestinal bacteria and the intestinal mucosal immune system and the impact on host 
health.  The targeted interactions are often referred to as immunomodulatory effects.  
There are various measures for determining immunomodulatory effects, including 
cytokine analysis
 
(Galdeano and Perdigon, 2004), antibody production
 
(Roller et al., 
2004; Fung et al., 2000), and lymphocyte proliferation
 
(Mohamadzadeh et al., 2005), as 
well as CD4 and CD8 T-cell lymphocyte ratios (Watzl et al., 1999).  Much of the 
research in this field has arisen from studies of the effects of probiotics, with additional 
studies addressing effects of prebiotics.  Prebiotics have the potential for similar impact 
as probiotics, since they are based on utilizing the natural intestinal bacteria to achieve 
positive benefits.  Probiotics can be defined as viable microorganisms, when 
administered in sufficient amounts, alter the intestinal microflora profile and confer a 
health benefit on the host organism (FAO and WHO, 2002; Galdeano and Perdigon, 
2004; Dieleman et al., 2003).  Prebiotics are often described as non-digestible 
oligosaccharides
 
(Morelli et al., 2003) which have a positive impact on the host by 
stimulating particular bacteria in the intestinal tract
 
(Roberfroid, 2000).  A further 
adaptation of this research is the development of synbiotics, which are a combination of 
both probiotics and prebiotics
 






Bacterial presence in the gut 
 There are over 400 species of bacteria living within the human gastrointestinal 
tract (Fang et al., 2000; Simon and Gorback, 1986).  These intestinal bacteria have been 
shown to be critical to numerous aspects of host health, including effects on the immune 
system
 
(Roberfroid, 2000) (which is the focus of my research), inflammatory bowel 
disease
 
(Dieleman et al., 2003), and even protection against toxins present in 
contaminated food
 
(Watzl et al., 1999).  Many genera of Lactic Acid Bacteria (LAB) 
such as Lactobacillus, as well as Bifidobacterium species are present in the intestine 
(Isolauri et al., 2001; Wallace et al., 2003), and it is these genera on which most prebiotic 
and probiotic research has been performed.  However, Lactobacilli and Bifidobacteria do 
not represent the majority of the colonic population, which includes several other genera, 
such as Clostridia and Bacteroides.  Much of the colonic microflora is as yet unculturable
 
(Eckberg et al., 2005), and can be effectively identified and mapped only by current 
molecular methods. 
It has been found that supplementation or modification of the intestinal microflora 
using probiotics can have beneficial effects on the host.  In cases where the normal 
bacterial profile has been disrupted, replenishment of the natural intestinal microflora can 
help to limit negative effects, such as oral antibiotic therapy
 
(Dieleman et al., 2003).  Not 
all cases of positive probiotic and prebiotic effects are the result of simply restoring 
microbial populations of the gut to normal levels however.   Immunomodulatory benefits 
have also been observed from the supplementation of the existing microflora with 
additional bacteria.  Supplementation with Lactobacillus casei and Lactobacillus 
bulgaricus has been reported to increase the activity of macrophages
 





2001), while L. bulgaricus and Lactobacillus acidophilus derived from yogurt have been 
shown to increase antibody production, specifically IgG and IgM (Mohamadzadeh, 
2005).  It has also been shown that supplementation with Lactobacillus rhamnosus GG 
can potentially modify levels of mucosal cytokine production
 
(Dieleman et al., 2003).  
However, in many cases, probiotic effects are strain specific.  There has been some 
evidence that probiotic bacteria must be viable in order to stimulate cytokine and 
antibody production
 
(Galdeano and Perdigon, 2004), although some debate surrounds 
this.  Another issue is providing biologically relevant levels of probiotic bacteria, such as 
those found in yogurt, which currently provide the most common intake of probiotics, 
and which in some cases do not have sufficient quantities of cells to provide the expected 
beneficial effects
 
(Akalin et al., 2007).  This means that other alternatives to providing 
probiotic bacteria as a supplement to enhance the immune system should be considered. 
 
Prebiotic fibres 
Prebiotics have the potential to have a significant impact as an alternative to 
consumption of probiotics.  The premise behind prebiotics is that they pass through the 
human digestive system undigested, and therefore can used as substrates by intestinal 
bacteria.  Examples of prebiotics include β-glucans from oats
 
(Su et al., 2007), inulin 
from chicory root (Roller et al., 2004; Su et al., 2007; Roberfroid, 2001), 
fructooligosaccharides (FOS) from beans
 
(Su et al., 2007), and even indigestible resistant 
starches
 
(Sajilita et al., 2006).  These prebiotics are then hydrolyzed and fermented by 
bacteria with the appropriate metabolic activity, allowing changes in growth and 
proliferation of certain bacteria, including L. acidophilus
 





2007), Bifidobacterium animalis lactis
 
(Su et al., 2007), L. casei (Su et al., 2007), 
Streptococcus thermophilus
 
(Akalin et al., 2007), and L. bulgaricus
 
(Akalin et al., 2007), 
and ultimately influencing gut microbial community profiles 
β-glucans are a major constituent of oat bran
 
(Tungland and Meyer, 2002) and 
barley
 
(Angelov et al., 2006), and are a well fermented dietary fibre
 
(Tungland and 
Meyer, 2002).  β-glucans are the primary source for monomeric glucose within the 
soluble portion of oat fibre
 
(Hansen et al., 1992).  They are also considered to be the 
major functional material within cereal fibres
 
(Angelov et al., 2006).  In fact, oat and 
barley have the highest β-glucan percentage of the cereals
 
(Wood and Beer, 1998; 
Manthey et al., 1999).  β-glucan has been used for a variety of functional purposes, 
including food processing, where it is used for thickening, stabilizing, and the gelling of 
food
 
(Burkus and Temelli, 1999).  It has been used for this purpose within low fat cheeses
 
(Brennen and Cleary, 2005).  In addition, it has been shown to increase the viability of 
probiotic Bifidobacterium animalis ssp. lactis
 
(Vasilijevic et al., 2007), indicating that β-
glucans can be utilized as a fermentable substrate by certain Bifidobacteria
 
(Wood and 
Beer, 1998; Jaskari et al., 1998) and other lactic acid bacteria (LAB) (Johansson et al., 
1998). 
Inulin is the major fibre constituent of wheat bran, and consists of short chained β 
1-2 linked fructose units, with terminal glucose units
 
(Le Blay et al., 1999).  It is 
considered a fructo-polysaccharide due to the relatively large chain length
 
(Le Blay et al., 
1999).  It is almost wholly resistant to degradation by mammalian digestive enzymes, but 
is readily fermented by various bacteria in the large intestine
 
(Roberfroid and Delzenne, 
1998), including bifidobacteria
 





prebiotic fibre supplementation can increase colonic IL-10 and interferon-gamma (IFNγ) 
 
(Roller et al., 2004).  Additional health benefits have been reported with inulin intake 
such as increased iron absorption, critical due to the common deficiency of dietary iron
 
Yeung et al., 2005).   Inulin is generally regarded as safe (GRAS) at high intake levels 
and therefore provides an optimal dietary fibre source without safety concerns for over-
ingestion
 
(Coussement, 1999). The average inulin intake of Americans is around 5g/ day
 
(Moshfegh et al., 1999), while safe intakes can range upward of 30g/day without any 
observed adverse effects (Coussement, 1999). 
Frucooligosaccharides also consist of short chain β1-2 linked fructose units, with 
terminal glucose units (Le Blay et al., 1999).  The difference between inulin and FOS is 
chain length, with FOS having a degree of polymerization of 3-10, and is considered to 
be an oligosaccharide
 
(Englyst et al., 1995).  FOS is estimated to be fermented up to 83%
 
(Scholz-Ahrens et al., 2001), and can stimulate growth of both lactobacilli and 
bifidobacteria (Le Blay et al., 1999).  FOS has been reported to have effects on the 
immune system, including upregulated IgA secretion in the Peyer’s Patches (PP), as well 
as increased secretion of both Th1 cytokines (IFNγ) and Th2 cytokines (IL-10)
 
(Hosono 
et al., 2003).  FOS has also been shown to modify the cultivatable fecal bacterial 
phylotypes, increasing numbers of inulin fermenting bacteria, particularly clostridia 
strains
 
(Gourgue-Jeannot et al., 2006).  This re-emphasizes the impact that dietary fibre 
has on the diversity of the intestinal bacterial community profile. 
Resistant starches are considered to be those starch products which are either fully 
or partially resistant to enzymatic degradation within the human small intestine
 
(Englyst 







(Scholz-Ahrens et al., 2001).  Sources of resistant starch include 
potatoes, maize, peas, and bananas
 
(Tungland and Meyer, 2002). Unlike other dietary 
fibres discussed, resistant starches do not fall under one defined description, but rather 
different types of resistant starch have been classified
 
(Englyst et al., 1992).  There 
appears to be a disagreement in the number of classifications necessary, as certain reports 
define three types of RS, while others classify RS into four different categories.  Utilizing 
the four category classification, type 1 RS includes starches physically inaccessible to 
enzymes, such as those in seeds, while type 2 RS is enzymatically resistant to α-amylase 
until gelatinized
 
(Tungland and Meyer, 2002).  Conversely, type 3 RS consists of 
previously digestible gelatinized starch which, due to the heating and cooling of food 
processing, has become retrograded, and therefore resistant
 
(Tungland and Meyer, 2002).  
Type four RS consists of those starches produced primarily by commercial processes
 
(Tungland and Meyer, 2002).  Despite these specific differences, resistant starch is 
chemically similar to other starches, containing glucose subunits linked by either α-D-(1-
4) or α-D-(1-6) bonds
 
(Sajilata et al., 2006).  Amylose, which is the main linear polymer 
of RS, consists of long chains of glucose linked by α-D-(1-4) bonds
 
(Sajilata et al., 2006).  
Amylopectin, which is more highly branched, also consists of α-D-(1-6) bonds, and is 
usually a larger molecule than amylase
 
(Sajilata et al., 2006).  Resistant starches, while 
relatively new in the field of dietary fibre research, have been shown to have a variety of 
positive benefits.  Within the large intestine, resistant starch can increase the amount of 
mucin produced, which provides protection against infection of the gut by foreign 
microbes
 
(Toden et al., 2007).  It is reportedly implicated in reduced risk of colon cancer
 





dietary intake of resistant starch was concurrent with reductions in red meat and animal 
fat in the diet
 
(O’Keefe, 2008). 
One major problem with many studies is that they are performed using in vitro 
based techniques, which do not consider the possible interactions between the intestinal 
bacteria and the impact on the host.  Examples include Su et al., (2007), Aryana et al., 
(2007), and Akalin et al., (2007).  Su et al., (2007) looked at several different prebiotics 
and their effects on probiotic growth in vitro.  However, they did not explore whether 
these probiotics would then have any effect on the mucosal immune system or Gut-
Associated Lymphoid Tissue (GALT).  A limited number of studies have used in vivo 
techniques and as a whole are still insufficient to provide comprehensive or conclusive 
data on the effect of the many different prebiotics available. This leaves many gaps in the 
current knowledge about prebiotic fibres and their immunomodulatory effect in vivo.  In 
addition, much of the research available looks at inulin type fibres, meaning many of the 
other prebiotic fibres are left relatively unstudied.  This leaves many gaps in current 
knowledge regarding the potential application of dietary fibre supplementation for 
modification of the immune system. 
 
Colonic bacteria community profiles can be modified through intake of dietary fibre 
Many studies have shown that the intestinal bacterial profile can be modified by 
dietary supplementation with different types of fibre.  A review by Tungland and Meyer 
(2002), lists numerous dietary fibres with effects on intestinal microflora, such as: gluco-
oligosaccharides, isomaltose, inulin, and FOS.  Many studies have reported increased 







(Gibson, 1998; Roberfroid et al., 1998).  Even less commonly used prebiotics such 
as lactulose have been shown to increase growth of intestinal lactobacilli species
 
(Madsen 
et al., 1999).  In another study, FOS fed to rats was reported to increase the total 
concentrations of intestinal LAB
 
(Le Blay et al., 1999).   Inulin has been shown to 
increase Bifidobacteria in humans
 
(Kruse et al., 1999).  The research described in this 
thesis is a continuation of collaboration between several labs exploring effects of dietary 
fibre on colonic microbial communities.  Previous work carried out through this 
collaboration has included identification of novel bacterial phylotypes (determined by 
16S sequencing) within the BBc rat colon as a result of feeding oat bran or wheat bran as 
dietary fibre.  It was found that while both oat bran and wheat bran induced changes in 
the gut microflora profile, at the end of the feeding trial, wheat bran had produced 
substantially more measureable novel phylotypes than oat bran
 
(Abnous et al., 2009) 
(Fig. 1).  This indicates that wheat bran fermentation in the intestine leads to increased 
colonic community diversity.  Many studies investigate only a limited range of types of 
bacteria when examining changes in bacterial diversity resulting from dietary fibre 
administration or in vitro systems assessing effects of fibre on bacterial growth.  This 
approach may be insufficient for determining the true extent of changes occurring in 
colonic bacterial populations, considering the diversity of the population and the fact that 
many of these bacteria are unculturable.  It has been shown that inulin can be fermented 
by species of Bifidobacterium, Bacteroides, Clostridium, Enterococcus, and 
Lactobacillus. However, each showed different fermentation efficiency, and yielded 
different growth potentials as a result
 





well suited for determining the changes that dietary fibre supplementation can have on 
the intestinal microflora profile, and any resultant immunomodulatory effects. 
Figure 1.  Unrooted phylogenetic tree representing phylogenetic relationships within 
colonic contents of BBc rats.  Rats were fed control diet alone, or control diet 
supplemented with either oat or wheat fibre.  Samples were collected on Day 0, 7, 14, and 
28 after start of feeding trial.  Data represents unique phylotypes for control (■), oat bran 
(●) or wheat bran (▲) for one trial (n = 8). Particular phylotypes, groups, or phyla 
identified include:  Bacteroides/Cytophaga phylum, Lactobacillus panis, Clostridium 
coccoides group, Clostridium leptum subgroup, Mycoplasma species, Eggerthella 
species, Bacillus-Lactobacillus-Streptococcus subdivision, Clostridium botulinum, 
Cyanobacteria, Proteobacteria, and Clostridium lituse-burense.  Figure adapted with 
permission from Martin Kalmokoff (Abnous et al., 2009). 
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Bacterial interaction with the intestinal mucosal immune system 
 The bacteria present in the lower intestinal tract have a number of different host 
cell types with which they can interact and potentially induce immunological effects.  
Some cells types within the immune system are only capable of interacting directly with a 
foreign antigen, while others, such as dendritic cells and intestinal epithelial cells (IEC) 
possess the ability to transport the antigen across the intestinal epithelial layers to the 
interior of the body and interact with lymphoid tissues present.  
One type of cell, making up most of the surface area of the intestinal tract, is the 
intestinal epithelial cell (IEC). IEC in fact have a dual role, in that they not only allow 
nutrients across the membrane, but simultaneously provide a physical barrier to protect 
the host from infection by foreign pathogens
 
(Nagler-Anderson, 2001).  IEC contain 
intercellular tight junctions between cells, which restrict passage of most small molecules 
through the epithelial layer
 
(Madara, 1998).  One specialized type of IEC are enterocytes, 
which are covered with microvilli on the luminal side (Kraehenbul and Neutra, 2000). 
These microvilli are covered with glycoproteins which create the Filamentous Brush 
Border Glycocalyx (FBBG), which can absorb nutrients without allowing transport of 
foreign pathogens
 
(Kraehenbul and Neutra, 2000).
  
Mucous is produced by specialized 
IEC, and serves as another physical barrier in host defence against pathogens.  IEC are 
able to respond directly to foreign pathogens by producing cytokines, which are capable 
of stimulating an immune response in the GALT
 
(Pitman and Blumberg, 2000). 
Another type of cell present within the epithelial layer are microfold cells (M 
cells)
 
(Nagler-Anderson, 2001).  M cells are similar to IEC with the exception that the 
membrane bound glycoproteins on the luminal side are absent
 





M cells are responsible for “sampling” the contents of the intestinal lumen and possess 
the capacity to transport bacteria and antigens across the epithelium through vesicles
 
(Nagler-Anderson, 2001).  They can then pass the sampled material into the GALT to 




 The GALT can be divided into two distinct regions: inductive and effector
 
(Nagler-Anderson, 2001).  In the inductive regions called Peyer’s Patches (PP), antigen 
transported into the PP by cells is taken up and processed by APC such as macrophages 
and DCs
 
(Nagler-Anderson, 2001).  A recent discovery is that DCs are also capable of 
extending through the epithelium to sample external antigens directly, and are capable of 
forming tight junctions with IEC to maintain the integrity of the intestinal epithelium
 
(Nagler-Anderson, 2001), thus providing an additional route for entry of bacteria and 
antigens into the GALT.  After antigens are brought into the PP, they can then be 
presented to T lymphocytes, and can also stimulate B lymphocytes.  Activated B and T 
lymphocytes then travel through the blood or lymph, via the MLN, recirculating and 
ultimately homing back to GALT effector sites such as the lamina propria (LP)
 
(Brandtzaeg et al., 1999), where a high density of IgA+ memory B cells are located.   
Memory cells in these “effector” locations are therefore capable of rapidly initiating an 
immune response through production of antibodies and cytokines. 
There are different isotypes or classes of antibodies which B cells can produce, 
including IgA, IgM, and IgG.  IgA can be produced systemically as a monomer, or 
secreted as a dimer (Nagler-Anderson, 2001).  Secretory IgA plays a critical role in the 





entry into the body, eliminating them by immune exclusion
 
(Macpherson and Uhr, 2004).  
Secretory IgA may also limit over-stimulation of the immune response, since it only 
weakly activates the complement system, which is involved in pro-inflammatory 
responses
 
(Kaetzel et al., 1991).  The importance of secretory IgA in limiting 
translocation of commensal bacteria into the body has been recognized only relatively 
recently
 
(Macpherson et al., 2000).  Secretory IgA in the MLN serves to 
compartmentalize intestinal commensals away from the systemic immune system, acting 
as a “firewall” to prevent unnecessary and potentially harmful activation of systemic 
responses to commensals
 
(Macpherson and Smith, 2006).  Another class or isotype of 
antibody is IgM, which is the first isotype produced in response to infection
 
(Stavnezer, 
1996).  IgG is produced later as a result of class-switching, as is IgA, and the majority of 
antibodies produced during a secondary or memory response are either IgG (at systemic 
locations) or IgA (at mucosal locations) (Stavnezer, 1996).   Class-switching to IgE can 
also occur, although IgE is normally present at low levels, and its production is involved 
in type 1 hypersensitivity reactions (allergies)
 
(Stavnezer, 1996). While B cells only 
produce one type of antibody at any one time, different antibody isotypes can be made 
through a process called class switching.  This is a process where genes encoding the 
antibody heavy chain of IgM are switched for genes encoding heavy chains from other 
antibody classes
 
(Litinskiy et al., 2002). 
There are many different cytokines, each with a different role to play in the 
immune system. IL-2 is produced primarily by Th1 cells, and is involved in pro-
inflammatory type responses such as activating macrophages, NK, and TC cells
 
(Nielsen 





regulating antibody production by B cells as well as in the differentiation of Th0 cells 
into Th2 cells
 
(Rincon et al., 1997).  IL-10 is also a Th2-derived cytokine
 
(Rimoldi et al., 
2005) and along with TGFβ, is able to assist in class switching to IgA
 
(Fagarasan and 
Honjo, 2003).  TGFβ is produced mostly by B cells and APC, and is the primary activator 
of class switching to IgA
 
(Stavnezer, 1996; Fayette et al., 1997).  TNFα is primarily a 
monocyte-derived cytokine
 
(Flach et al., 1998) which is involved in pro-inflammatory 
Th1 responses
 
(Coffman et al., 1988). 
 
Research Objectives 
The broad objective of this research project was to investigate the potential for 
different dietary fibres to influence an in vivo intestinal microbial community, and to 
examine associated effects on the immune system.  The current study will analyze effects 
on cytokine and lymphocyte profiles in different tissues, at both systemic and mucosal 
locations.  This will provide evidence as to the extent of immune system modification as 
a result of intake of dietary fibre present in different fibre sources, including oat, wheat 
bran, resistant starch and FOS.  Analysis of liver and spleen tissues allows determination 
of whether specific cytokines are increased systemically and not just locally within the 
mucosal tissues.  Analysis of the following cytokines was performed: 
 IL2 – Mainly pro-inflammatory with anti-inflammatory implications 
 IL4 – Anti-inflammatory and involved in class switching 
 IL6 – Both pro-inflammatory and anti-inflammatory roles 
 IL10 – Anti-inflammatory cytokine 





Analysis of the spleen, blood, and mesenteric lymph node lymphoid populations 
allow for determination of the immunomodulatory impact on both systemic and mucosal 
immunity, including changes in T helper cell populations (CD4 and CD8).  Analysis of 
mesenteric lymph node and cecal tissue provides information regarding effects on the 
intestinal mucosal immune system.  And finally, cecal and fecal IgA analysis provides 
information regarding changes in antibody secretion within the gastrointestinal tract.  
Related changes in antibody isotype profiles at the systemic level can be made based on 
serum antibody measurements. 
Ultimately, the information gained is expected to provide insight into the capacity 
for prebiotics to be used in the modification of the immune system.  It is expected that 
dietary oat bran and wheat bran will significantly impact the immune system of the rats 
used in this study.  This may help to develop more specific studies targeting particular 
fibres present within supplements such as oat and wheat bran ultimately providing 
support for nutritional supplementation with prebiotics in order to enhance or modify the 












MATERIALS AND METHODS 
 
Animal Care and Diets 
All animal care protocols were approved by the Health Canada Ottawa Animal 
Care Committee prior to commencement of respective studies. Treatment and housing 
was performed according to Canadian Council on Animal Care (CCAC) guidelines.  
Biobreeding (BBc) weanling rats (aged 28-42 days old) were obtained from the rat 
colony at Health Canada’s Animal Resource Division facility (Ottawa, Canada).   
Three separate trials were performed, with rats being fed ad libitum.  For trials 1 
and 2, rats were divided into control, oat bran, and wheat bran groups.  The control diet 
was an AIN-93G formulation (Test Diet, USA), while the oat and wheat bran groups 
were supplemented with 5% oat or wheat bran dietary fibre (American Association of 
Cereal Chemists, USA), respectively. Diets were maintained at 20% protein, 58-63% 
carbohydrate, 7% fat, 5% dietary fibre, 0-2% water, and 0-1% ash.  Dietary fibre was 
maintained at 5% utilizing wood cellulose within control group, and energy density of the 
diets were comparable within 1% of each other.  For trial 3, additional diets were added.  
A 5% resistant starch group was included which utilized the prior control group.  An 
additional group and control were added separately.  This diet consisted of Purina Chow 
5001 (Purina Mills, Pembroke, Ont.) for control, or 5% fructooligosaccharides (FOS) 
(Encore Technologies, USA) supplemented in the Purina chow.  A separate control group 
was required for this experimental diet based on previous work performed at the Health 
Canada facility.  Feeding trials were 34 days in length, with initial weaning onto control 





collaborating laboratories.  Euthanasia was performed using O2/CO2 asphyxiation at 
percentages and times determined by the CCAC. 
 
Tissue Homogenization procedure 
Spleen and liver tissues were initially placed in 5mL/1g Phosphate Buffered 
Saline (137mM NaCl, 2.68mM KCl, 1.01mM Na2HPO4, 1.38mM KH2PO4) containing 
1% protease inhibitor cocktail (Sigma-Aldrich, USA).  Tissues were homogenized using 
Tissuemiser (Fisher Scientific, USA) for 1 minute, followed by centrifugation (Eppendorf 
5415D) for 30 minutes at 16,100 g.  The supernatant was collected, then centrifugation 
and collection was repeated twice more.  The samples were then stored at -80°C until use. 
 
Fecal and cecal sample preparation 
Samples were weighed and diluted 1g/2mL with 10g/L BSA in PBS.  Samples 
were vortexed, incubated for 10 minutes at room temperature, then centrifuged at 4000g 
for 30 minutes.  Supernatants were collected and frozen at -80°C until use. 
 
Cytokine analysis from tissue homogenates 
Quantitative analysis of cytokines within tissue homogenates was performed 
using cytokine specific commercial Enzyme Linked Immunosorbant Assay (ELISA) kits 
(Biosource, USA) using modified manufacturer’s protocols and analyzed on a Synergy 






All manufacturer volumes added to ELISA plates were halved due to usage of 
half-volume ELISA plates to conserve available samples.  Initial coating of wells with 
primary antibody for IL-2, IL-10, and TNFα was at concentrations of 1.25µg/mL using 
Coating Buffer B (4.3g NaHCO3 and 5.3g Na2CO3 in 1L H2O at pH 9.4).  For coating 
with IL-4 antibody, concentration was 1.25µg/mL in Coating Buffer A (8.0g NaCl, 1.13g 
Na2HPO4, 0.2g KH2PO4, and 0.2g KCl in 1L H2O at pH 7.4). Plates were coated with 
50µL per well and incubated in fridge at 4°C overnight for 12-18 hours.   
Washing was performed by tapping plate onto absorbent paper, filling well with 
wash buffer (9.0g NaCl and 1mL Tween 20 in 1L H2O at pH 7.4), and tapping wells clear 
onto fresh absorbent paper.   
Unbound well surfaces were blocked with 150µL per well of assay buffer (8.0g 
NaCl, 1.13g Na2HPO4, 0.2g KH2PO4, and 0.2g KCl in 1L H2O at pH 7.4) for 1 hour at 
room temperature.   
Standards were prepared using serial dilutions to provide concentration ranges of 
1000pg/mL to 15.625pg/mL, with the blank containing only assay buffer.  Samples for 
the following cytokines were diluted using assay buffer as previously determined from 
titration assays: Liver IL-2 – 1 in 10, Liver IL-4 -1 in 5, Liver IL-10 – 1 in 2, Liver TNFα 
– 1 in 2, and all spleen samples were undiluted. The biotinylated detection antibodies 
were prepared using the following dilutions: IL-2 – 0.125µg/mL using assay buffer with 
5% Fetal Bovine Serum (FBS), IL-4 – 0.050µg/mL using assay buffer with 5% FBS, IL-
10 – 0.125µg/mL using 5% FBS, and TNFα – 0.37µg/mL using only assay buffer.  
Liquid was removed from wells by inverted tapping of plate onto absorbent paper.  After 





triplicate.  Then 25µl of detection antibody was also added to all wells, and the plate was 
gently tapped on the sides to aid in mixing.   
The plates were then incubated for 2 hours at room temperature, and those assays 
using undiluted samples were incubated on a shaker at 600 rpm as determined in previous 
titration assays, to assist in increased diffusion of reactions due to the viscous nature of 
the undiluted samples.  The wells were then washed 5 times.   
The streptavidin conjugated horseradish peroxidase (HRP) enzyme for each 
cytokine kit was prepared by dilution in assay buffer to these concentrations: IL-2 – 
0.15µg/mL, IL-4 – 0.2µg/mL, IL-10 – 0.2µg/mL and TNFα – 0.3µg/mL.  The HRP 
solution was added at 50µl/well and incubated for 30 minutes at room temperature.  The 
plate was then washed 5 times.   
To each well, 50 µl of Tetramethylbenzidine (TMB) (Sigma Aldrich, Canada) 
was added and incubated for various times (15-25 minutes) to achieve by visual 
observation, colour development corresponding to final optical density ranges of 1.0-2.0, 
optimal for the microplate reader.  After sufficient incubation time, 50µl of 1.8N H2SO4 
reaction stop solution was added to each well.  The absorbance was then measured at 
450nm wavelength, and results calculating using the software 4-parameter curve fit for 
standard. 
 
Immunoglobulin analysis from fecal and cecal sample 
Analysis of immunoglobulins from fecal and cecal samples was performed using 





manufacturer’s protocols and analyzed on a Synergy HTTR microplate reader using KC4 
version 3.4 software (Bio-Tek, USA).   
 
All volumes recommended by the manufacturer for ELISAs were halved due to 
usage of half-volume ELISA plates to conserve available samples.  Wells were initially 
coated with 50 µl of primary antibody for either IgA, IgG, or IgM, diluted to 
concentrations of 10µg/mL using coating buffer (0.05M carbonate-bicarbonate, at pH 
9.6).  Plates were incubated for 60 minutes at room temperature.   
Wells were washed three times using wash solution (50mM Tris, 0.14M NaCl, 
0.05% Tween 20, at pH 8.0).  To all wells, 100µl of blocking solution (50mM Tris, 
0.14M NaCl, 1% bovine serum albumin (BSA), at pH 8.0) was added and incubated for 
30 minutes at room temperature.  The wells were then washed three times.   
Standards were diluted using sample diluents (50mM Tris, 0.14mM NaCl, 1% 
BSA, 0.05% Tween 20, at pH 8.0) to create standard curves with the following ranges: 
IgA – 1000 to 15.625ng/mL, IgG – 2000 to 31.25 ng/mL, IgM – 500 – 7.8ng/mL.  
Samples were diluted using sample diluent as follows: IgA - 1 in 30, IgG – undiluted, and 
IgM – undiluted.  The standards and samples were added at 50µl/well in triplicate and 
incubated for 60 minutes at room temperature.  Wells were then washed 5 times.   
The HRP antibody conjugates were diluted in sample diluent to prepare the 
following concentrations as determined is previous titration assays:  IgA - 10ng/mL, IgG 
– 5ng/mL, IgM – 1 ng/mL.  To each well, 50µl of working HRP solution was added and 





To each well was added 50µl TMB substrate (Sigma Aldrich, Canada), and 
incubated for 13 minutes, at which time 50µl/well of 2M H2SO4 was added.  The 
absorbance was then measured at 450nm wavelength, and results calculating using the 
software 4 parameter curve fit for standard. 
 
Primary Cell Culture Preparation 
Spleen and mesenteric lymph nodes (MLN) were removed from animals 
sacrificed at the Health Canada ARD in Ottawa, Canada.  The animals were sacrificed 
and dissected for tissues over a period of three days, referred to as Tissue sets A, B, and 
C respectively.  
 The spleens were chopped into 3-4 pieces and immediately immersed in MEM 
media (Sigma Aldrich, Canada) containing 2.2g/L sodium bicarbonate, 100mg/L 
kanamycin (Sigma-Aldrich, Canada), 100U/L of penicillin (Sigma-Aldrich, Canada), and 
50µg/L streptomycin (Sigma-Aldrich, Canada) at pH 7.1 and 10% fetal bovine serum 
(FBS).   
The MLN were screened through 70um cell dissociation strainers (BD 
Biosciences, Canada) using rubber plunger tips and washed with MEM.  All cells were 
shipped on ice and processed at UOIT within 24 hours.   
Cell preparation for primary culture is outlined in Appendix A.  Spleen pieces 
were screened through cells strainers, and washed with MEM.  The cells were 
centrifuged for 10 minutes at 300g and supernatant removed by vacuum aspiration.  The 
cells were then re-suspended in 5mL Tris buffered ammonium chloride lysis buffer 





incubated for 2 minutes before 9mL MEM with 10% FBS was added.  Cells were 
centrifuged for 10 minutes at 300g, and supernatant was removed by vacuum aspiration.  
Cells were re-suspended in 1mL MEM with 10% FBS and counted using a 
hemocytometer.  Cells were adjusted to 10
6
 cells/mL.  For preparation of MLN cells, 
cells were centrifuged at 300g for 10 minutes, then re-suspended in 1mL MEM with 10% 
FBS, counted, and adjusted to 10
6
 cells/mL.   
After adjustments of all cell concentrations, cells were divided into two groups: 
whole cell populations for use in immunoglobulin and cytokine production, and 
macrophage isolation for nitric oxide production, phagocytic analysis, and hydrogen 
peroxide production analysis.   
Due to limitations imposed by poor cell yields, tissue sets B and C were treated 
differently then tissue set A.  Tissue set A had adherence performed for all three expected 
assays, while for tissue sets B and C, whole cell populations were utilized for the 
phagocytosis and respiratory burst assays.  The adherence step for isolation of 
macrophages was performed on tissue culture treated cell culture dishes (Corning brand, 
Sigma-Aldrich, USA).  Adherence step was for 90 minutes at 37°C and 5% CO2.  After 
adherence, cells were removed from plate using 8mL trypsin and incubated for 5 minutes 
at 37°C and 5% CO2. Cells were washed and collected from plate using MEM with 10% 
FBS, and separated into two tubes.  The cells were then centrifuged for 10 minutes at 300 
g.  One tube for each cell set was re-suspended in MEM with 10% FBS, while the other 
was re-suspended in KRPG for the respiratory burst assay. Cells were counted and 
adjusted to 10
6







After preparation of macrophages for primary culture, cells were plated at 10
6
 
macrophages per mL, and challenged with 10µg/mL or either Escherichia coli 
lipopolysaccharide (LPS) O55:B5 (Sigma-Aldrich, Canada) or Pansorbin cells 
(Staphylococcus aureus, Calbiochem, USA).  Cells were incubated for 3 days at 37°C 
and 5% CO2 in 96 well plates.  After incubation, cells were centrifuged at 300g for 10 
mins prior to collecting supernatant for analysis. 
 
Analysis of macrophage nitric oxide production from cell cultures was quantified 
using a commercially available nitrate colorimetric assay kit (Cayman Chemical, USA) 
analyzed on a Synergy HTTR microplate reader using KC4 version 3.4 software (Bio-
Tek, USA).  A linear standard curve was prepared using the included NaNO3 standard, 
diluted with assay buffer to give final concentrations of 0-35 uM and standard volumes of 
40µl.  The samples were diluted in half with assay buffer and 40µl added to wells in 
triplicate.  Blank wells were plated in duplicate by using 200µl of assay buffer only.  
After adding samples and standards, 10µl each of nitrate reductase cofactor preparation 
and nitrate reductase enzyme preparation was added to all wells except blank wells.  Plate 
was incubated 1 hour at room temperature and covered. Griess reagents R1 and R2 were 
added to all wells except blank and incubated for ten minutes.  Absorbance was then 







Analysis of the reactive oxygen species hydrogen peroxide was quantified using a 
commercially available fluorometric assay kit (Molecular Probes, Invitrogen, USA) and 
analyzed on a Synergy HTTR microplate reader using KC4 version 3.4 software (Bio-
Tek, USA).  Stock reaction buffer was prepared by diluting 5X reaction buffer with 
reverse osmosis (RO) water.  The horseradish peroxidase stock solution was prepared by 
adding one vial of HRP to 1mL of stock reaction buffer.  Amplex red reagent was 
prepared by adding 60µl of dimethyl sulfoxide (DMSO) to one vial of amplex red.  
Reaction mixture was prepared by combining 25µl amplex red, 50µl HRP, and 4.925mL 
of reaction buffer. To appropriate wells of a black sided 96 well plate, 90µl of the 
reaction mixture was added, and warmed for 10 minutes at 37°C.  For tissue set A, 20 µl 
of 10
4
 macrophages per mL suspended in KRPG were added to the all wells except 
negative control, which received 20µl KRPG only.  For tissue sets B and C, 20 µl of 10
6
 
cells/mL suspended in KRPG were added per well.  Challenge wells also received 
10µg/mL phorbol 12-myristate 13 acetate (PMA) (Sigma Aldrich, Canada), which can 
induce respiratory burst effects. Preliminary testing was performed using LPS 055:B5 at 
a 10µg/mL concentration, similar to previous studies (Bitzinger et al., 2008), however 
insufficient responses were observed.  Fluorescence was immediately measured from 
plate bottom at 530nm excitation, and 590nm emission.  The plate was then incubated at 







Analysis of macrophage phagocytic activity from cell cultures was quantified 
using the commercially available Vybrant fluorometric kit (Molecular Probes, Invitrogen, 
USA) and analyzed on a Synergy HTTR microplate reader using KC4 version 3.4 
software (Bio-Tek, USA).  After preparation of cells for primary culture, cells were 
plated at either 10
4
 macrophages (Tissue set A) or 10
6
 cells (Tissue sets B and C).  All 
samples and controls were plated black sided 96 well plates in triplicate.  Negative 
control wells had 100µl of MEM, while positive control baseline wells had 100µl of 
cells.  Challenged wells also received 20µg/mL of LPS 055:B5.  The plate was quickly 
spun at 300-400g, and incubated for 1 hour at 37°C and 5% CO2.  The fluorescent E. coli 
suspension was prepared by adding one vial of concentrated Hank’s Balanced Salt 
Solution (HBSS) to one vial of fluorescein labeled E. coli K12 particles.  This solution 
was diluted 1:10 with Milli-Q water and solution was sonicated and vortexed to eliminate 
precipitates.  Supernatant was removed from wells by vacuum aspiration and 90µl of 
fluorescent suspension added to all wells.  Plates were incubated for 2 hours at 37°C and 
5% CO2 to allow for phagocytosis of fluorescent particles.  Trypan blue was used to 
quench any extracellular fluorescence from remaining particles and was prepared by 
diluted 1:5 with Milli-Q water and sonicated to eliminate precipitates.  After incubation, 
fluorescent suspension was removed by vacuum aspiration, and 90µl trypan blue 
suspension added to each well.  After incubating for 1 minute at room temperature, 
trypan blue was removed by vacuum aspiration and fluorescence was measured from the 






Flow Cytometric analyses 
 
Flow cytometric analysis was performed at Health Canada in Ottawa, Ontario 
using a Becton Dickinson fluorescent activated cell sorter (FACS) and standard operating 
procedures.  Gating techniques were standard and similar to those use in Shingadia et al. 
(2001). Fluorescent antibodies were initially titrated to correct dilutions for optimal 
detection.  Antibodies used included, CD3, CD4, CD8, CD161a, CD45RA, CD172, 
CD68, CD25, Foxp3, IgA, IgG, and IgM.  All antibodies were obtained from Biolegend, 




Analysis of variance (ANOVA) was performed using either Graphpad Instat for 
one-way ANOVA with Tukey’s post-hoc test or Graphpad Prism for two-way ANOVA 
with Bonferroni’s post-hoc test where p < 0.05. Graphs were created using Sigmaplot and 
error bars represent Standard Error of the Mean (SEM).  Data for separate trials was 
combined if no significant difference between trials was detected using a two-way 










Dietary Fibre supplementation with wheat or oat fibre does not induce pro-inflammatory 
responses 
  
 In order to assess the potential for increased inflammatory response due to dietary 
fibre supplementation, several different markers and tissues were assessed.  No 
significant changes in liver TNFα levels were observed due to either oat bran or wheat 
bran fibre supplementation relative to controls (Fig. 2).  Splenic TNFα and IL-6 were also 
tested but were below the level of detection by ELISA. Additionally, IL-2 levels were not 
significantly increased over basal levels in either the liver (Fig. 3) or the spleen (Fig. 4) in 
response to either fibre treatment relative to controls.   
 
Dietary fibre does not change systemic tissue IL-10 Levels 
 In order to determine the ability of dietary fibre to induce changes in regulatory 
cytokines, IL-10 levels were quantified in both liver and spleen tissues.  Oat bran and 
wheat bran did not induce significant changes in liver IL-10 levels in either Trial 1 (Fig. 
5) or Trial 2 (Fig. 6).  Levels of splenic IL-10 also remained unchanged in response to 
either dietary treatment for both Trial 1 (Fig. 7) and Trial 2 (Fig. 8) when compared to 
controls. 
 
Effects of dietary fibre treatment on Immunoglobulin levels 
Several different measures were taken in order to determine local effects of wheat 
or oat fibre treatment within the intestinal immune system, including measurement of 





significantly due to wheat bran fibre supplementation (Fig. 9).  However, no significant 
differences were observed for IgA measured in fecal samples (Fig. 10).  Cecal IgM and 
IgG levels were below the limit of detection by ELISA, a finding which is typical for 
intestinal immunoglobulin isotypes.  
 
Effects of fibre on lymphocyte and macrophage numbers 
Effects of wheat and oat bran supplementation on B and T cell numbers, 
macrophage/neutrophil numbers and on NK numbers were compared in spleen, MLN and 
in blood by flow cytometry.  Numbers of helper and cytotoxic T cells were also 
determined by enumerating CD4+ and CD8+ T cells respectively.  No changes were 
observed in cell population profiles in blood (Table 1). However, double positive 
(CD4+CD8+) T cells in the spleen showed a significant increase for wheat bran treatment 
in comparison to both the control and oat bran treatments (Table 2). The major effects 
were observed in MLN lymphocyte population profiles (Table 3).  Dietary wheat bran 
supplementation produced a significant decrease in total T cell numbers within the MLN 
as determined by the number of CD3+ cells (Fig. 11).  This change in total T cell number 
appeared to reflect a decrease in numbers of CD4+ T cells, and not CD8+ T cells, with 
numbers of CD4+ T cells in the MLN being significantly lower in wheat bran than in oat 
bran treated rats, although not significantly different from controls (Table 3).  This 
decrease in MLN T cell numbers was also concurrent with an increase in B cell numbers 






Effects of dietary fibre on systemic tissue IL-4 levels 
A trend (p < 0.1) towards decreased liver IL-4 levels was observed, and the 
treatments were subsequently compared to control using T-tests to identify which 
treatment was producing the effect.  It was determined that wheat bran significantly 
decreased liver IL-4 levels, indicating systemic effects of wheat bran fibre treatment (Fig. 
13).  However, these effects were not seen in the spleen where no significant differences 








































Figure 2.  TNFα levels in BBc rat liver.  Rats were fed control diet alone, or control diet 
supplemented with either oat or wheat fibre.  Data are means (±SEM) of two trials (n = 


































Figure 3.  IL-2 levels in BBc rat liver.  Rats were fed control diet alone, or control diet 
supplemented with either oat or wheat fibre.  Data are means (±SEM) of two trials (n = 



































Figure 4.  IL-2 levels in BBc rat spleen for Trial 2.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 




































Figure 5.  IL-10 levels in BBc rat liver for Trial 1.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 





































Figure 6.  IL-10 levels in BBc rat liver for Trial 2.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 




































Figure 7.  IL-10 levels in BBc rat spleen for Trial 1.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 



































Figure 8.  IL-10 levels in BBc rat spleen for Trial 2.  Rats were fed control diet 
alone, or control diet supplemented with either oat or wheat fibre.  Data are means 
(±SEM) of one trial (n = 7).  Effects of dietary fibre were not significant (p = 









Figure 9.  IgA levels in BBc rat cecal contents.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of two 
trials (n = 16).  Values with different letters (a,b) differ significantly (p < 0.05) as 


































Figure 10.  IgA levels in BBc rat fecal contents for Trial 2.  Rats were fed control diet 
alone, or control diet supplemented with either oat or wheat fibre.  Data are means 
(±SEM) of one trial (Control:  n = 6, Oat:  n = 5, Wheat: n = 7).  Effects of dietary fibre 











Figure 11.  T lymphocyte levels (CD3+) in BBc rat MLN.  Rats were fed control diet 
alone, or control diet supplemented with either oat or wheat fibre.  Data are means 
(±SEM) of one trial (n = 5). Values with different letters (a,b) differ significantly (p < 









Figure 12.  B lymphocyte levels in BBc rat MLN.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 
trial (n = 5). Values with different letters (a,b) differ significantly (p < 0.05) as 









Figure 13.  IL-4 levels in BBc rat liver.  Rats were fed control diet alone, or control diet 
supplemented with either oat or wheat fibre.  Data are means (±SEM) of two trials (n = 
16).  Values with different letters differ significantly (p < 0.05) as determined by t-test. A 
































Figure 14.  IL-4 levels in BBc rat spleen for Trial 1.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 




































Figure 15.  IL-4 levels in BBc rat spleen for Trial 2.  Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 







































1.1 47.1+/-0.7 16.8+/-0.3 2.9+/-0.1 60.5+/-1.9 1.7+/-0.1 
Oat 
63.2+/-
1.2 46.8+/-0.9 16.2+/-0.4 2.9+/-0.1 62.1+/-1.7 1.7+/-0.1 
Wheat 
62.3+/-
0.6 45.5+/-0.7 16.2+/-0.4 3.0+/-0.1 62.2+/-2.4 1.3+/-0.2 
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Double Positive T 
Cells (CD4+8+) 
NK Cells  
(CD3-
CD161a+) 
Control 49.4+/-2.3 32.7+/-2.2 13.3+/-0.5 1.58+/-0.2 2.02+/-0.3 
Oat 48.2+/-0.6 31.5+/-0.4 13.1+/-0.5 0.74+/-0.1 1.05+/-0.1 





 Data are shown as a mean percentage of total cell population +/- SE, n = 5 
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Table 3. Mononuclear cell population profiles in Mesenteric Lymph Nodes
1 
     
Treatment 











Control 55.6+/-0.4 16.8+/-0.5 1.0+/- 0.0 26.2+/-1.5 








 Data are shown as a mean percentage of total cell population +/- SE, n = 5 
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 There has been an increase in the study of dietary fibre effects on health 
parameters in recent years, including effects on heart health, anti-cancer properties, and 
blood lipid levels. One study found that resistant starch in combination with B. lactis 
would assist in pro-apoptotic responses to carcinogen exposure
 
(Le Leu et al., 2005).  In 
recent years there has been increased research into the immunomodulatory effects of 
dietary fibre, but there are still gaps and problems with some of this research, including 
contradictions in study results which may reflect the different designs of the experiments 
used
 
(Scholz-Ahrens et al., 2001).  As one review stated, evidence is only preliminary 
that modification of colonic microflora is able to provide health benefits
 
(Roberfroid, 
2000).  For example, one study has found that FOS fermentation does not increase 
Bifidobacteria growth, which opposes findings in other studies and common conceptions 
about the impact of FOS on gut microbial communities
 
(Gourgue-Jennot et al., 2006).   
A clinical study found that synbiotic supplementation with Bifidobacteria lactis, 
Lactobacilli acidphophilus, and inulin was able to increase levels of the probiotics
 
(Casiraghi et al., 2007), but they did not investigate whether any immune effects resulted.  
One interesting study tested the effects of combining oats and LAB to create a “health 
drink” with properties of both prebiotics and probiotics
 
(Angelov et al., 2006). Their 
justification of this as a health drink appears to be that whole grain oats are associated 
with beneficial health effects, as are LAB, with the prebiotic fibres in the oats acting as 
fermentation substrate for the LAB.  However, they provided no evidence that the 
combination would have a positive effect on the immune system.  Instead, they simply 





potential bioactivity and immunomodulatory effects they might have. As well, many 
studies investigating dietary fibre have been performed in vitro, an approach that does not 
allow for effective analysis of effects on gastrointestinal community diversity or 
subsequent effects on the immune system.   
Thus the aim of this research was to determine whether dietary supplementation 
with different types of fibres can modify the immune response in a BBc rat model, to 
determine the range of these effects, and through collaborative work, to consider these 
effects in concert with the impact on colonic microbial community diversity. 
 
Dietary oat bran and wheat bran do not stimulate pro-inflammatory effects 
 Within the immune system, there are two major patterns of cytokine production, 
those produced by Th1 cells and primarily responsible for pro-inflammatory responses, 
and those produced by Th2 cells which generally involve regulation and suppression of 
the inflammatory response, as well as regulating antibody production.   
Within the pro-inflammatory Th1 category, both IL-2 and TNFα play critical 
roles
 
(Dang et al., 2008).  Reduced serum TNFα levels have been associated with 
increased fecal Bifidobacterium levels in elderly humans
 
(Roller et al., 2004).  The 
cascade of factors resulting from pro-inflammatory markers such as IL1β, IL6, and TNFα 
is enormous, with significant negative repercussions
 
(Jeschke et al., 2004).  In excess, 
these cytokines can cause host damage by modifying production of other cytokines, 
chemokines, adhesion molecules (such as intracellular adhesion molecule 1 (ICAM-1)
 
(Wang et al., 2006) and angiogenesis
 





The release of TNFα within the intestinal mucosa can lead to a significant 
increase in localized inflammatory cells such as macrophages, which can subsequently 
result in impairment of mucosal function such as mucin production
 
(Neu et al., 2002).  
The positive role of TNFα in the immune system should not be overlooked however.  
TNFα is one of the initial cytokines produced in response to bacterial infection, and is 
therefore critical in priming and activating the immune system to respond to foreign 
pathogens
 
(Karlsson et al., 2002).  In fact, despite the previous mention of tumorigenesis 
resulting from TNFα overproduction, in moderation it is also capable of protection 
against tumour development
 
(Gomez-Flores et al., 1999), in part through induction of 
apoptosis
 
(Sellers and Fisher, 1999).  This shows that proper immunomodulation of this 
cytokine is critical to health.  In this study, no changes in TNFα were observed due to 
either oat bran or wheat bran supplementation, suggesting that neither treatment increases 
pro-inflammatory responses.   
 Another cytokine measured was IL-2.  While typically considered a Th1 cytokine, 
it also plays a role in controlling B cell activity by co-stimulating CD40 activated B cells 
to produce antibodies
 
(Litinskiy et al., 2002). In addition IL-2 has been associated with 
optimal induction of Foxp3+ regulatory T cells
 
(Davidson et al., 2007; Zheng et al., 
2007), a function which is typically anti-inflammatory.  However, IL-2 can also be 
associated with a pro-inflammatory Th1 profile, and Th1 cells are the primary producers 
of IL2
 
(Fiorentino et al., 1989).  In fact the pro-inflammatory response resulting from 
elevated IL-2 levels is sufficient to cause measurable damage to intestinal tissue
 
(Dang et 
al, 2008).  IL-2 is involved in increased activity of natural killer cells
 
(Nielsen and 





activated by T cells producing IL-2
 
(Tao and Stout, 1993).   Several studies have shown 
that changes in the intestinal microflora
 
(Coffman et al., 1988) can impact the levels of 
IL-2 produced.  It has previously been shown that certain E. coli strains are capable of 
inducing murine dendritic cells to produce IL-2
 
(Granucci et al., 2001).  In contrast, 
Bifidobacterium infantis 35624 has been shown to decrease the levels of IL-2 produced in 
the spleen
 
(Sheil et al., 2006).  However, since neither oat or wheat fibre treatments  
produced any significant changes in IL-2 production relative to controls in either the liver 
or spleen tissues, IL-2 does not appear to be a factor in the potential immunomodulatory 
effect of dietary oat bran or wheat bran supplementation. 
Oxidative stress markers were also examined in this study.  Reduced paraoxonase 
activity in plasma (Appendix A) would reflect an increase in oxidative damage associated 
with inflammation
 
(Camps et al., 2009).  Since paraoxonase activity is responsible for 
reducing oxidized LDL levels
 
(Aviram and Rosenblat, 2004), LDL oxidation (Appendix 
B) is another measure that can be used to determine the level of pro-inflammatory 
responses.  However, these two biomarkers were unaffected by either wheat or oat bran 
treatment, suggesting that these dietary regimens do not cause oxidative stress.  In 
addition, in the oat bran group, serum antioxidant activity increased significantly, 
indicating improved antioxidant status.  In turn, this shows that oat bran may have anti-
inflammatory effects, but as this is the only significant result obtained for the oat bran 






Regulatory IL-10 is not increased due to oat bran or wheat bran supplementation 
 It has previously been reported that dietary fibre in the form of inulin can 
significantly increase IL-10 production in the intestinal immune system
 
(Roller et al., 
2004).  The cytokine IL-10 is an important regulator of pro-inflammatory responses, and 
is critical in inhibiting feedback mechanisms found within the T cell system
 
(Li and 
Flavell, 2008).  IL-10 is capable of effecting this inhibition in multiple ways.  First, it can 
directly inhibit the maturation of antigen presenting cells (APC) which are responsible for 
presenting antigen to T cells and their subsequent differentiation
 
(Li and Flavell, 2008).  
As well, the actual process of naïve T cell differentiation can be inhibited by IL-10
 
(Li 
and Flavell, 2008).  In addition, these T cells may subsequently produce IL-10, 
introducing a negative feedback mechanism capable of limiting a pro-inflammatory 
cascade induced by activation of Th1 and cytotoxic T cells
 
(Li and Flavell, 2008).  As no 
significant differences in systemic IL-10 were found in response to either oat bran or 
wheat bran treatments, there is no evidence that IL-10 contributes to immunomodulatory 
effects of these dietary fibre supplements.  It is possible that differences in IL-10 levels 
are present at the mucosal level, which the future trial will address through cytokine 
analysis of cecal tissue. 
 
Wheat Bran Fibre significantly decreases IgA levels in Cecal contents 
 The role for IgA within the body is extremely varied.  The increased bacterial 
diversity observed within the wheat bran group indicates the ability of dietary fibre 





changes in IgA levels, since changes in bacterial communities are followed by IgA 
secretion, providing a feedback mechanism for controlling novel phylotypes
 
(Suzuki, 
2007).  Therefore over time, as bacterial diversity changes, IgA secretion responds by 
increasing to control overgrowth, possibly suppressing microflora changes and 
maintaining homeostasis. This would explain the changes observed during the time 
course study on novel phylotypes shown in Figure 1.  This possibility was not addressed 
in previous trials, as only one time point for fecal samples was taken.  The future trial 3 
analyses will include measurement of multiple time points, to determine if there is 
chronological effect on IgA secretion.   
Secretory IgA is the form which is secreted across mucosal membranes and is 
commonly released as a dimer (Corthesy, 2007). This dimer is formed by connecting two 
monomers together with a J chain, a polypeptide produced by those cells which secrete 
antibodies
 
(Cerutti, 2008).  Without the production of J chains, only monomeric IgA is 
produced, which cannot be transported as the secreted form, and a significant decrease in 
foreign pathogen elimination is observed
 
(Mora and Von Andrian, 2008).  J chains are 
required for secretion because they interact with the polymeric immunoglobulin receptor, 
which is responsible for transporting antibodies across the cell surface of mucosal 
epithelial cells
 
(Mostov and Deitcher, 1986).  It is therefore possible that the observed 
decreased cecal IgA levels reflect changes in the transcriptional regulation of J chain 
polypeptides
 
(Brandtzaeg, and Johansen, 2005).  This is also likely, since IgA+ B cells in 
lymphoid tissues, in particular the MLN, show decreased basal levels of J chain 
expression when compared to other regions of the gut mucosa (Brandztaeg et al., 2005; 





numbers were increased, a subsequent decrease in J chain regulation may lead to an 
overall decrease in secreted IgA.  J chain transcriptional regulation is mediated by 
different cytokines, including IL-2, IL-4, IL-5, and IL-6
 
(Brandtzaeg and Johansen, 
2005), which may subsequently modify levels of secreted IgA by indirectly affecting 
levels of J chain expression. 
 
Wheat Bran Fibre decreases IL-4 levels systemically 
 The distal nature of the liver in relation to the intestinal immune system makes it 
suitable for studying systemic effects on the immune system of the host.  It has 
previously been shown that a variety of physiological effects can be linked to microbial 
fermentation and interaction with the intestinal mucosa.  Short chain fatty acids resulting 
from carbohydrate fermentation, especially acetate, propionate and butyrate are capable 
of producing noticeable effects on the liver, including decreased fatty acid synthesis and 
esterification
 
(Delzenne et al., 2000).  The liver also has the greatest population of 
macrophages in the body, which are capable of inducing significant systemic effects 
through cytokine release
 
(Ayala et al., 1991; Ayala et al., 1991).  In addition, Kupffer 
cells, specialized macrophages within the liver are also capable of exerting local effects 
in the liver
 
(Cerutti, 2008).  This may have particular implications in instances where 
bacteria are carried by dendritic cells across intestinal mucosa and to systemic tissues 
such as the liver, a situation where liver macrophages would play a role in pathogen 
clearance
 
(Rescigno et al., 2000).  The link between mucosal and systemic immunity is 
further reinforced by a study illustrating that in the absence of a large portion of the large 
intestine, B cells were completely absent from the liver
 





the mucosa-associated lymphoid tissue (MALT) and systemic tissues do not operate in 
complete isolation – interactions between these compartments are ongoing.  Therefore, 
the significant changes observed in liver IL-4 in this study could reflect events in the 
MALT and lend support to the hypothesis that dietary fibre, and the resulting changes in 
microflora profiles can exert systemic effects as well as local effects at the mucosal level. 
 IL-4, along with other cytokines including TGFβ, IL-10, IL-5 and IL-6, is 
involved in regulating IgA class switching by B cells
 
(Brandtzaeg and Johansen, 2005).  
IL-4 is also involved in IgG class switching
 
(Litinskiy et al., 2002), although in this 
study, levels of cecal and fecal IgG were below limits of detection, so potential effects on 
IgG could not be determined.  In addition, as previously discussed, IL-4 is involved in J 
chain transcriptional regulation, and decreased levels of IL-4 may lead to decreased 
levels of J chain polypeptide production, subsequently reducing the levels of secreted IgA 
as seen in the cecal contents. 
  The reduced levels of hepatic IL-4 may reflect a more widespread effect of 
dietary fibre on IL-4 that would also be evident in mucosal tissues.  Although these were 
not available for the present study, future work aims to assess the effects of dietary wheat 
bran fibre on IL-4 levels in MLN, cecal and intestinal tissues.   It is also possible that the 
decreased hepatic IL-4 levels are directly responsible for the decreased cecal IgA levels, 
due to the potential for direct interactions between the intestinal mucosa and the liver 
through the hepatic portal vein.  Antigens have been shown to pass directly from the 
intestinal mucosa to the liver through the hepatic portal vein, bypassing the primary 
bloodstream altogether
 
(Macpherson and Smith, 2006).  There are limited serum samples 





cytokines IL-4 and TGFβ if volume permits, allowing determination of whether hepatic 
IL-4 levels reflect in changes in the circulating IL-4. 
 
Effects of dietary fibre on lymphocyte populations in the Mesenteric Lymph Nodes 
 There are several different sites in the intestinal mucosa where bacteria and 
antigens can be sampled, but they are sampled primarily in the Peyer’s patches
 
(Kunkal et 
al., 2003).  The MLN is a key location for IgA+ B cells
 
(McWilliams et al., 1977), and 
has also been shown to serve a “firewall” role, preventing bacterial translocation, 
including translocation of commensals, through IgA production
 
(Macpherson et al., 
2000).  We observed a significant decrease in total T lymphocyte populations in the MLN 
in response to wheat fibre treatment, which appears to reflect a decrease in CD4+ Th cell 
numbers. 
It has been shown in other studies that certain lactobacilli are able to modify T-
lymphocyte activity
 
(Easo et al., 2002), and their subsequent production of cytokines 
responsible for antibody production.  Therefore, it is possible that the changes in 
microflora associated with wheat bran fibre supplementation lead to changes in T cell 
activity and cytokine production, leading to reduced numbers of T lymphocytes in the 
MLN.   
Given the importance of Th cells in supporting B cells, our finding that dietary 
wheat bran led to increased levels of B cells in the MLN may appear contradictory in 
light of the  decreased levels of T cells also found in the MLN.  Th cells are commonly 
involved in B cell activation, and a decrease in Th cells could potentially cause a decrease 





mechanisms by which B cells are activated, those which are T cell-dependent those 
which are independent of T cells
 
(Brandtzaeg and Johansen, 2005).   
If the activation of B cells were solely T cell dependent, than a decrease in T cell 
numbers could lead to a reduction in B cell numbers.  However, B cells can be activated 
through a T cell-independent mechanism involving binding of B cell receptors for B cell 
activation factor (BAFF), B cell maturation antigen (BCMA), along with Transmembrane 
Activator and Calcium modulator and Cyclophilin ligand activator (TACI) (Litinskiy et 
al., 2002). Several different types of APC express B lymphocyte stimulator protein 
(BLyS), which binds to these receptors on B cells
 
(Litinskiy et al., 2002).  In addition, 
APC produce A Proliferation-Inducing Ligand (APRIL), which binds to BCMA, and can 
induce a pathway for anti-apoptosis and proliferation that is independent of T cells
 
(Litinskiy et al., 2002).  In fact, APRIL is also involved in T cell independent class 
switching and upregulation of IgA secretion
 
(Litinskiy et al., 2002). Thus, the decrease in 
MLN T lymphocyte numbers concurrent with an increase in B lymphocyte numbers may 
be explained through activation of T cell-independent mechanisms, potentially due to the 
observed changes in colonic microflora 
In addition, our finding that wheat bran fibre led to a decrease in cecal IgA 
concurrent with an increase in MLN B cell numbers may also appear contradictory.  
However, an increase in B cell numbers does not necessarily imply an increase in IgA+ B 
cells.  In the first trial, only total B cell numbers were enumerated.  The third trial in 
progress is attempting to address this limitation by quantifying the percentage of IgA+ B 
cells relative to IgG+ and IgM+ B cells, in order to better clarify the effects of dietary 





 It is also necessary to consider to the effect of T helper cells in the effects 
observed.  The observed decrease in CD4+ T helper cells could play a role in the 
apparent discrepancy between increased MLN B cell numbers accompanied by decreased 
cecal IgA.  Despite the increased number of B cells, they may produce less IgA due to a 
lack of T helper cell support, including decreased production of IL-4.  Reduced IL-4 
production would be expected to result in less effective class switching.  Taken together, 
these results suggest that T helper cell-dependent processes were also influenced by 
wheat bran intake, and were manifested in reduced B cell production of IgA.  This is 
further support for the hypothesis that dietary fibre supplementation, specifically wheat 
bran, is capable of immunomodulation and that this effect is potentially linked to changes 
in the intestinal microflora profile. 
 
Future directions 
 Based on the research so far, several questions remain to be addressed.  First, is 
IL-4 directly involved in the observed effects on cecal IgA?  In order to answer this 
question, two follow-up measures will be analyzed.  Cytokine analysis has not been 
performed thus far on serum, so serum samples will be tested for both IL-4 and TGFβ, as 
both of these cytokine are involved in class switching and so can influence IgA 
production.  Serum sample volume permitting, immunoglobulin isotype profiles of the 
serum samples will also be analyzed, to determine whether changes in IgM, IgG, or IgA 
are evident at the systemic level.  Another question relates to the increase in B cell 
numbers in the MLN concurrent with the decrease in IgA in response to wheat bran 





IgA+ B cells, a hypothesis which is being explored in the third trial by determining 
numbers of IgM+, IgG+ and IgA+ B cells by immunofluorescence and flow cytometry.  
It is expected that the results of this future work will allow for a clearer picture of the 
immunomodulatory effects of dietary fibre supplementation. 
 One additional direction which should be explored is utilizing a diseased model, 
such as exhibiting inflammatory bowel disorder.  This would allow for the observed 
effects to be evaluated in a challenged animal, where the benefits of immunomodulatory 
effects from dietary fibre supplementation can be directly observed. 
 
Work in progress 
 Additional experiments are currently in progress for continuation of this research.  
A third feeding trial has been performed at the Animal Research Division facility at 
Health Canada in Ottawa, Ont.  This feeding trial is similar in approach to the previous 
two trials, with the inclusion of two additional experimental groups (resistant starch and 
inulin) and two corresponding appropriate control diets.    
Experiments have been performed to determine the level of lymphocyte and 
macrophage activity within both spleen and MLN.  Primary culture of cells from both 
these tissues has been performed for whole cell populations and for isolated 
macrophages.  Whole cell populations were utilized for determination of macrophage 
phagocytic activity, respiratory burst measured through hydrogen peroxide production, as 
well as both antibody and cytokine production.  Macrophages were isolated for 





In addition, data on the effects of dietary fibre on lymphocyte and macrophage 
populations was collected by flow cytometry for spleen, MLN and blood populations, for 
the markers listed in Appendix E. 
Both mucosal (MLN, colon, jejunum, ileum, cecum) and systemic (spleen) tissues 
were collected for cytokine analysis, and serum and plasma were collected for analysis of 
cytokine profiles and immunoglobulin isotypes.   
Cecal contents were collected at the end of the feeding trial, and fecal pellets were 
collected at intervals throughout the trial to allow for analysis of IgA throughout the trial, 
at time points corresponding to sampling for colonic microbial population diversity 
profiles. 
Serum was also analyzed for the following markers which are indicative of liver 
damage:  alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, 
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Appendix A – Additional measures from feeding trial 1 – Paraoxanase Levels 
 
Levels of paraoxonase activity of BBc rat plasma. Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 






















Appendix B – Additional measures from feeding trial 1 – Oxidized LDL Levels 
Levels of oxidized LDL in BBc rat plasma. Rats were fed control diet alone, or control 
diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of on trial (n = 





















Appendix C – Additional measures from feeding trial 1 – Total Antioxidant Status 
Concentration of total antioxidants in BBc rat plasma. Rats were fed control diet alone, or 
control diet supplemented with either oat or wheat fibre.  Data are means (±SEM) of one 
trial (n = 10).  Value with different letters (a,b) differ significantly (p < 0.05) as 




























Appendix E – Flow Cytometry Targets and Markers 
 
 





CD3, CD4, CD8 
 
T Cells, B Cells, NK Cells CD3, CD45, CD45RA, CD161a 
 
Macrophage CD3, CD45, CD68, CD172 
 
Immunoglobulins CD45RA, IgA, IgG, IgM 
 
Foxp3 CD3, CD4, CD25, Foxp3 
 
Foxp3 Isotype Control CD3, CD4, CD25, Isotype AF647 
 
 
